Covered recipient · General Payments record
JEANNA LYNN KNOBLE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$40,245.24
- Reported across 306 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,837.50 | 1 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,440.00 | 1 |
| Food and Beverage | $1,011.04 | 35 |
| Long term medical supply or device loan | $897.30 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,003.69 | 18 |
| PFIZER INC. | $1,570.62 | 3 |
| Janssen Scientific Affairs, LLC | $130.78 | 1 |
| Pharmacosmos Therapeutics Inc. | $58.12 | 3 |
| SpringWorks Therapeutics, Inc. | $48.11 | 2 |
| Incyte Corporation | $41.70 | 2 |
| SERVIER PHARMACEUTICALS LLC | $41.58 | 2 |
| EISAI INC. | $27.72 | 1 |
| Astellas Pharma US Inc | $25.69 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.21 | 1 |
| Lilly USA, LLC | $21.97 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.44 | 1 |
| AVEO Pharmaceuticals, Inc. | $20.35 | 1 |
| Genentech USA, Inc. | $19.54 | 1 |
| EMD Serono, Inc. | $19.50 | 1 |
| Acerta Pharma LLC | $18.81 | 1 |
| Adaptive Biotechnologies Corporation | $17.20 | 1 |
| Iovance Biotherapeutics, Inc. | $16.70 | 1 |
| Janssen Biotech, Inc. | $16.40 | 1 |
| Amneal Pharmaceuticals LLC | $14.62 | 1 |
| Daiichi Sankyo Inc. | $14.21 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (46)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.